These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2418435)

  • 1. A survey of diagnostic amniocenteses in Oxford from 1974-1981.
    Terzian E; Boreham J; Cuckle HS; Wald NJ; Bobrow M; Lindenbaum R; Turnbull AC
    Prenat Diagn; 1985; 5(6):401-14. PubMed ID: 2418435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
    Crandall BF; Kulch P; Tabsh K
    Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing first-trimester transcervical chorionic villus sampling and second-trimester amniocentesis.
    Ammälä P; Hiilesmaa VK; Liukkonen S; Saisto T; Teramo K; von Koskull H
    Prenat Diagn; 1993 Oct; 13(10):919-27. PubMed ID: 8309899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.
    Cruikshank DP; Varner MW; Cruikshank JE; Grant SS; Donnelly E
    Am J Obstet Gynecol; 1983 May; 146(2):204-11. PubMed ID: 6189400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation.
    Crandall BF; Chua C
    Prenat Diagn; 1995 Apr; 15(4):339-43. PubMed ID: 7542382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal genetic diagnosis in 3000 amniocenteses.
    Golbus MS; Loughman WD; Epstein CJ; Halbasch G; Stephens JD; Hall BD
    N Engl J Med; 1979 Jan; 300(4):157-63. PubMed ID: 153471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal age and amniocentesis: should this be lowered to 30 years?
    Crandall BF; Lebherz TB; Tabsh K
    Prenat Diagn; 1986; 6(4):237-42. PubMed ID: 2944088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic amniocentesis: technique and results in 1,000 first trimester amniocenteses (author's transl)].
    Schmidt W; Gabelmann J; Müller U; Voigtländer T; Hager HD; Schroeder TM; Garoff L; Kubli F
    Geburtshilfe Frauenheilkd; 1980 Sep; 40(9):761-8. PubMed ID: 6448181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Report of 8 years' experience in the prenatal diagnosis of genetic defects. II. Results].
    Weise W; Gabriel D
    Zentralbl Gynakol; 1984; 106(4):216-29. PubMed ID: 6711184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study.
    Simpson NE; Dallaire L; Miller JR; Siminovich L; Hamerton JL; Miller J; McKeen C
    Can Med Assoc J; 1976 Oct; 115(8):739-48. PubMed ID: 61796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of amniocentesis and laboratory findings in a series of 1500 prenatal diagnoses.
    Verjaal M; Leschot NJ; Treffers PE
    Prenat Diagn; 1981 Jul; 1(3):173-81. PubMed ID: 7346822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in Ohio amniocentesis utilization during the first twelve years (1972-1983), and frequency of chromosome abnormalities observed.
    Naber JM; Huether CA; Goodwin BA
    Prenat Diagn; 1987; 7(1):51-65. PubMed ID: 2950387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
    Wald N; Cuckle H; Nanchahal K
    Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amniocentesis in the West Midlands: report on 1000 births.
    Webb T; Edwards JH; Cameron AH; Crawley JM; Hulten M; Rushton DI; Thompson RA
    J Med Genet; 1980 Apr; 17(2):81-6. PubMed ID: 6155469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
    Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
    Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening.
    Am J Obstet Gynecol; 1989 Mar; 160(3):575-81. PubMed ID: 2467563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal genetic diagnosis in 350 amniocenteses.
    Crandall BF; Lebherz TB
    Obstet Gynecol; 1976 Aug; 48(2):158-62. PubMed ID: 133307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic amniocentesis: a six-years experience in an isolated region of northeastern Quebec (Canada).
    Hamel G; Simard L; Gagné R; De Braekeleer M
    Genet Couns; 1993; 4(2):103-8. PubMed ID: 7689325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
    Sant-Cassia LJ; MacPherson MB; Tyack AJ
    Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.